NCT03544151

Brief Summary

The investigators will perform a study to create formula for the optimal insertion depth of right internal jugular vein catheter.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 1, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

July 10, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2019

Completed
Last Updated

March 24, 2020

Status Verified

March 1, 2020

Enrollment Period

1.4 years

First QC Date

May 21, 2018

Last Update Submit

March 22, 2020

Conditions

Insertion Depth of Central Venous Catheter

Outcome Measures

Primary Outcomes (1)

  • The distance

    The distance between the insertion point and the junction between right atrium and superior vena cava

    After insertion of the Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V) and during operation

Interventions

Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V)DEVICE

Swan-Ganz CCOmbo V insertion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for cardiac surgery were studied

You may qualify if:

  • Adult patient over 18 years of age undergoing mitral valve or/and tricuspid valve
  • Surgery under general anesthesia, requiring Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V) insertion through the right internal jugular vein.

You may not qualify if:

  • A change in the mediastinal structure from previous neck surgery,thoracic surgery or cardiac surgery
  • Extracardiac vascular anomaly
  • Anatomical abnormality in neck and thorax
  • Refusal to enrol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diansan Su

Shanghai, Shanghai Municipality, 200127, China

Location

Study Officials

  • qi lu, Dr.

    Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2018

First Posted

June 1, 2018

Study Start

July 10, 2018

Primary Completion

November 25, 2019

Study Completion

December 27, 2019

Last Updated

March 24, 2020

Record last verified: 2020-03

Locations

CN(1)